Corrigendum: The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
Shuzhen Tan1,2† 
Zesong Li3† Kai Li2 Yingqi Li2 Guosheng Liang2 Zhenye Tang2 Jianhao Kang2 Wenqing Chen2 Minhua Li2 Zhilin Zou2 
Guoliang Pi4* 
Xiao Zhu1,2,3*- 1School of Laboratory Medicine, Hangzhou Medical College, Hangzhou, China
- 2Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Guangdong Medical University, Zhanjiang, China
- 3Guangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital (Shenzhen Institute of Translational Medicine), Shenzhen, China
- 4Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
A corrigendum on
The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
by Tan, S., Li, Z., Li, K., Li, Y., Liang, G., Tang, Z., Kang, J., Chen, W., Li, M., Zou, Z., Pi, G., and Zhu, X. (2021). Front Endocrinol 6:75. doi: 10.3389/fcell.2021.741521
In the published article, there was an error in affiliation 1. Instead of “Anhui Clinical and Preclinical Key Laboratory of Respiratory Disease, Department of Respiratory Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China”, it should be “School of Laboratory Medicine, Hangzhou Medical College, Hangzhou, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: lung cancer, N6-methyladenosine, prognosis, regulators, risk scores
Citation: Tan S, Li Z, Li K, Li Y, Liang G, Tang Z, Kang J, Chen W, Li M, Zou Z, Pi G and Zhu X (2022) Corrigendum: The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers. Front. Cell Dev. Biol. 10:843275. doi: 10.3389/fcell.2022.843275
Received: 25 December 2021; Accepted: 27 January 2022;
Published: 07 March 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Tan, Li, Li, Li, Liang, Tang, Kang, Chen, Li, Zou, Pi and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guoliang Pi, piguoliang_2004@163.com; Xiao Zhu, bioxzhu@yahoo.com
†These authors have contributed equally to this work